Cargando…

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic pathogen that can transmit from dromedary camels to humans, causing severe pneumonia, with a 35% mortality rate. Vaccine candidates have been developed and tested in mice, camels, and humans. Previously, we developed a vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alharbi, Naif Khalaf, Aljamaan, Fahad, Aljami, Haya A., Alenazi, Mohammed W., Albalawi, Hind, Almasoud, Abdulrahman, Alharthi, Fatima J., Azhar, Esam I., Barhoumi, Tlili, Bosaeed, Mohammad, Gilbert, Sarah C., Hashem, Anwar M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413082/ https://www.ncbi.nlm.nih.gov/pubmed/36016218 http://dx.doi.org/10.3390/vaccines10081330

Ejemplares similares

High Rate of Circulating MERS-CoV in Dromedary Camels at Slaughterhouses in Riyadh, 2019
por: Aljasim, Taibah A., et al.
Publicado: (2020)

Transcriptomic Profiling of Dromedary Camels Immunised with a MERS Vaccine Candidate
por: Hala, Sharif, et al.
Publicado: (2021)

Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2019)

Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
por: Bosaeed, Mohammad, et al.
Publicado: (2022)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area
por: Alroqi, Fayhan, et al.
Publicado: (2021)

Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination
por: Meyer zu Natrup, Christian, et al.
Publicado: (2023)

Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016
por: Degnah, Afnan A., et al.
Publicado: (2020)

Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera
por: Almasaud, Abdulrahman, et al.
Publicado: (2019)

Non-SARS Non-MERS Human Coronaviruses: Clinical Characteristics and Outcome
por: Saib, Israa, et al.
Publicado: (2021)

Circulation of Non-MERS Coronaviruses in Imported Camels In Saudi Arabia
por: Alraddadi, Y., et al.
Publicado: (2019)

Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience
por: Algaissi, Abdullah A., et al.
Publicado: (2020)

Challenge infection model for MERS-CoV based on naturally infected camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2020)

Cross-sectional prevalence study of MERS-CoV in local and imported dromedary camels in Saudi Arabia, 2016-2018
por: Tolah, Ahmed M., et al.
Publicado: (2020)

Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping
por: Alharbi, Naif Khalaf, et al.
Publicado: (2015)

Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
por: Alharbi, Naif Khalaf, et al.
Publicado: (2021)

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
por: Alharbi, Naif Khalaf, et al.
Publicado: (2017)

MERS Coronaviruses in Dromedary Camels, Egypt
por: Chu, Daniel K.W., et al.
Publicado: (2014)

Mers Coronavirus Infection in Dromedary Camels
por: van den Brand, J.M.A., et al.
Publicado: (2016)

Serological identification of MERS-CoV in camels of Wasit province, Iraq
por: AL-Taee, Hala S. R., et al.
Publicado: (2023)

Expression and Cellular Immunogenicity of a Transgenic Antigen Driven by Endogenous Poxviral Early Promoters at Their Authentic Loci in MVA
por: Orubu, Toritse, et al.
Publicado: (2012)

MERS-CoV in Camels but Not Camel Handlers, Sudan, 2015 and 2017
por: Farag, Elmoubasher, et al.
Publicado: (2019)

Development and Evaluation of Enzyme-Linked Viral Immune Capture Assay for Detection of SARS-CoV-2
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Cross-sectional prevalence study of MERS-CoV in local and imported dromedary camels in Saudi Arabia, 2016-2018
por: Tolah, A., et al.
Publicado: (2020)

Identification of MERS-CoV in dromedary camels
por: Ferguson, Neil M, et al.
Publicado: (2014)

Mers-CoV: From camels to humans
por: Memish, Z.
Publicado: (2016)

Camels charged with passing MERS virus to people
Publicado: (2013)

MERS Coronavirus in Dromedary Camel Herd, Saudi Arabia
por: Hemida, Maged G., et al.
Publicado: (2014)

MERS-CoV spillover at the camel-human interface
por: Dudas, Gytis, et al.
Publicado: (2018)

MERS vaccines advance, but will humans or camels get the jab?
por: Khamsi, Roxanne
Publicado: (2015)

Deciphering MERS-CoV Evolution in Dromedary Camels
por: Du, Lin, et al.
Publicado: (2016)

Molecular Evidence of Influenza A Virus Circulation in African Dromedary Camels Imported to Saudi Arabia, 2017–2018
por: Alghamdi, Abdulaziz, et al.
Publicado: (2019)

Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines
por: Kandeel, Mahmoud, et al.
Publicado: (2023)

Seroprevalence of COVID-19 in Riyadh city during the early increase of COVID-19 infections in Saudi Arabia, June 2020
por: Alenazi, Mohammed W., et al.
Publicado: (2022)

Seroprevalence of Dromedary Camel HEV in Domestic and Imported Camels from Saudi Arabia
por: El-Kafrawy, Sherif Aly, et al.
Publicado: (2020)

Geographic Distribution of MERS Coronavirus among Dromedary Camels, Africa
por: Reusken, Chantal B.E.M., et al.
Publicado: (2014)

Correction: MERS-CoV spillover at the camel-human interface
por: Dudas, Gytis, et al.
Publicado: (2018)

MERS and the dromedary camel trade between Africa and the Middle East
por: Younan, M., et al.
Publicado: (2016)

Risk factors of SARS-CoV-2 infection in cancer patients pre- and post-vaccination
por: Alsagaby, Suliman A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qqu5fcv6pfvfjangg05bvn6ib9